Literature DB >> 12584347

Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.

Makoto Inoue1, Yumiko Tokusumi, Hiroshi Ban, Takumi Kanaya, Tsuyoshi Tokusumi, Yoshiyuki Nagai, Akihiro Iida, Mamoru Hasegawa.   

Abstract

The formation of nontransmissible virus-like particles (NTVLP) by cells infected with F-deficient Sendai virus (SeV/deltaF) was found to be temperature sensitive. Analysis by hemagglutination assays and Western blotting demonstrated that the formation of NTVLP at 38 degrees C was about 1/100 of that at 32 degrees C, whereas this temperature-sensitive difference was only moderate in the case of F-possessing wild-type SeV. In order to reduce the NTVLP formation with the aim of improving SeV for use as a vector for gene therapy, amino acid substitutions found in temperature-sensitive mutant SeVs were introduced into the M (G69E, T116A, and A183S) and HN (A262T, G264R, and K461G) proteins of SeV/deltaF to generate SeV/M(ts)HN(ts)deltaF. The use of these mutations allows vector production at low temperature (32 degrees C) and therapeutic use at body temperature (37 degrees C) with diminished NTVLP formation. As expected, the formation of NTVLP by SeV/M(ts)HN(ts)deltaF at 37 degrees C was decreased to about 1/10 of that by SeV/deltaF, whereas the suppression of NTVLP formation did not cause either enhanced cytotoxicity or reduced gene expression of the vector. The vectors showed differences with respect to the subcellular distribution of M protein in the infected cells. Clear and accumulated immunocytochemical signals of M protein on the cell surface were not observed in cells infected by SeV/deltaF at an incompatible temperature, 38 degrees C, or in those infected by SeV/M(ts)HN(ts)deltaF at 37 or 38 degrees C. The absence of F protein in SeV/deltaF and the additional mutations in M and HN in SeV/M(ts)HN(ts)deltaF probably weaken the ability to transport M protein to the plasma membrane, leading to the diminished formation of NTVLP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584347      PMCID: PMC149769          DOI: 10.1128/jvi.77.5.3238-3246.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication.

Authors:  Y Sakai; K Kiyotani; M Fukumura; M Asakawa; A Kato; T Shioda; T Yoshida; A Tanaka; M Hasegawa; Y Nagai
Journal:  FEBS Lett       Date:  1999-08-06       Impact factor: 4.124

2.  A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding.

Authors:  G Mottet; A Mühlemann; C Tapparel; F Hoffmann; L Roux
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

3.  Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus.

Authors:  M Tashiro; N L McQueen; J T Seto; H D Klenk; R Rott
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase.

Authors:  Y Kanegae; K Takamori; Y Sato; G Lee; M Nakai; I Saito
Journal:  Gene       Date:  1996-11-28       Impact factor: 3.688

5.  Characterization of Sendai virus M protein mutants that can partially interfere with virus particle production.

Authors:  Geneviève Mottet; Virginie Müller; Laurent Roux
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

6.  Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo.

Authors:  C M Sanderson; H H Wu; D P Nayak
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Budding of rabies virus particles in the absence of the spike glycoprotein.

Authors:  T Mebatsion; M Konig; K K Conzelmann
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

8.  Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light.

Authors:  K Tsung; J H Yim; W Marti; R M Buller; J A Norton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Efficient gene transfer to airway epithelium using recombinant Sendai virus.

Authors:  Y Yonemitsu; C Kitson; S Ferrari; R Farley; U Griesenbach; D Judd; R Steel; P Scheid; J Zhu; P K Jeffery; A Kato; M K Hasan; Y Nagai; I Masaki; M Fukumura; M Hasegawa; D M Geddes; E W Alton
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

10.  A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression.

Authors:  H O Li; Y F Zhu; M Asakawa; H Kuma; T Hirata; Y Ueda; Y S Lee; M Fukumura; A Iida; A Kato; Y Nagai; M Hasegawa
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

View more
  19 in total

1.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 2.  Methods for making induced pluripotent stem cells: reprogramming à la carte.

Authors:  Federico González; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Rev Genet       Date:  2011-02-22       Impact factor: 53.242

3.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.

Authors:  Hiroshi Ban; Naoki Nishishita; Noemi Fusaki; Toshiaki Tabata; Koichi Saeki; Masayuki Shikamura; Nozomi Takada; Makoto Inoue; Mamoru Hasegawa; Shin Kawamata; Shin-Ichi Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-05       Impact factor: 11.205

Review 4.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 5.  Vectorology and factor delivery in induced pluripotent stem cell reprogramming.

Authors:  Kejin Hu
Journal:  Stem Cells Dev       Date:  2014-04-16       Impact factor: 3.272

6.  Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.

Authors:  N Tanaka; K Araki; D Mizokami; Y Miyagawa; T Yamashita; M Tomifuji; Y Ueda; M Inoue; K Matsushita; F Nomura; H Shimada; A Shiotani
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

7.  Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Authors:  Ken Nishimura; Masayuki Sano; Manami Ohtaka; Birei Furuta; Yoko Umemura; Yoshiro Nakajima; Yuzuru Ikehara; Toshihiro Kobayashi; Hiroaki Segawa; Satoko Takayasu; Hideyuki Sato; Kaori Motomura; Eriko Uchida; Toshie Kanayasu-Toyoda; Makoto Asashima; Hiromitsu Nakauchi; Teruhide Yamaguchi; Mahito Nakanishi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

8.  A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.

Authors:  Olga Malykhina; Mark A Yednak; Peter L Collins; Paul D Olivo; Mark E Peeples
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

9.  Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.

Authors:  Yogish C Kudva; Seiga Ohmine; Lucas V Greder; James R Dutton; Adam Armstrong; Josep Genebriera De Lamo; Yulia Krotova Khan; Tayaramma Thatava; Mamoru Hasegawa; Noemi Fusaki; Jonathan M W Slack; Yasuhiro Ikeda
Journal:  Stem Cells Transl Med       Date:  2012-05-30       Impact factor: 6.940

10.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.